{"id":449919,"date":"2021-03-03T15:03:13","date_gmt":"2021-03-03T20:03:13","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=449919"},"modified":"2021-03-03T15:03:13","modified_gmt":"2021-03-03T20:03:13","slug":"athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/","title":{"rendered":"Athenex Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Athenex, Inc."},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, March  03, 2021  (GLOBE NEWSWIRE) &#8212; Kaplan Fox &amp; Kilsheimer LLP (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wCV_l0w8pppxiPTD4OgW8VuWjaqkRr9IeViJ2sFLmSa2_QSdOvH2uHkxT5KK3aD8bQAQ5qF7jAm5Y10K1eTX7A==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.kaplanfox.com<\/u><\/a>) is investigating claims on behalf of investors of Athenex, Inc. (\u201cAthenex\u201d or the \u201cCompany\u201d) (NASDAQ: ATNX).<\/p>\n<p align=\"justify\">On March 1, 2021, Athenex issued a press release reporting its fourth quarter results and disclosing receipt of a complete response letter (\u201cCRL\u201d) from the FDA regarding its new drug application for Oral Paclitaxel Plus Encequidar for the treatment of metastatic breast cancer. In the CRL, the FDA expressed the following:<\/p>\n<ul type=\"disc\">\n<li>Concerns about safety risks associated with increase in neutropenia-related sequelae;<\/li>\n<li>Concerns regarding the primary endpoint assessment conducted by the Blinded Independent Central Review (BICR); and<\/li>\n<li>Recommendation that Athenex conduct a new clinical trial in a patient population with metastatic breast cancer representative of the population in the U.S.<\/li>\n<\/ul>\n<p align=\"justify\">Following this news, Athenex\u2019s shares plummeted by $6.64 per share, over 54%, to close at $5.46 per share on March 1, 2021.<\/p>\n<p align=\"justify\">If you purchased or otherwise acquired Athenex securities and would like to discuss our investigation, please contact us by emailing <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LcWzhxN-XQr6NQShD_hEUfPWQ--CoFxWRlqZXph_Hxt-JlrKZX4BAUZhnXsjhPC3-FgCDVOB5XCm7iQ3CcADoO-5Cmp_tFeNqNW_JlUxYc4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>pmayer@kaplanfox.com<\/u><\/a> or by calling (646) 315-9003.<\/p>\n<p align=\"justify\">This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p>\n<p align=\"justify\">Kaplan Fox &amp; Kilsheimer LLP, with offices in New York, San Francisco, Los Angeles, Chicago and New Jersey, has many years of experience in prosecuting investor class actions. For more information about Kaplan Fox &amp; Kilsheimer LLP, you may visit our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wCV_l0w8pppxiPTD4OgW8YtxPSqubO--Zr8Ml_fTqrodq1_JKLCv4jMPVfpOj0hj6b-E_iKn4E5EEeZmpbMugQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.kaplanfox.com<\/u><\/a>. If you have any questions about this investigation, your rights, or your interests, please contact:<\/p>\n<p align=\"justify\">Donald R. Hall <br \/> KAPLAN FOX &amp; KILSHEIMER LLP <br \/> 850 Third Avenue, 14th Floor <br \/> New York, New York\u00a010022 <br \/> (646) 315-9003 <br \/> E-mail: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DLdbbEfmAXS7Ju5D1mLX64zxpLvqY4rDH1SGkFKzYIa1bLnwKTLLTUhEPSq3RI6VxyaPaoB_U2omoY7I19Y7BJPLWLLkrrcIEkUqdxC3fJU=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>dhall@kaplanfox.com<\/u><\/a><\/p>\n<p align=\"start\">Laurence D. King <br \/> KAPLAN FOX &amp; KILSHEIMER LLP <br \/> 1999 Harrison Street, Suite 1560 <br \/> Oakland, California 94612 <br \/> (415) 772-4704 <br \/> Fax:\u00a0 (415) 772-4707 <br \/> E-mail: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OJo9QoAApDpXaiGPFc3dCN2MXIdQ9KjVPWDDubP0hU2Y7TpvG6S4c_IbY_dAuBc7nNW4X8Q76yul7e_okrAHubC7GWnPXbSQ7tx5rEC79-k=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>lking@kaplanfox.com<\/u><\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Mzk0MyM0MDQ3MjEyIzIwMjA4OTE=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/4717b1da-b5db-43ab-affc-fe578264298c\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, March 03, 2021 (GLOBE NEWSWIRE) &#8212; Kaplan Fox &amp; Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Athenex, Inc. (\u201cAthenex\u201d or the \u201cCompany\u201d) (NASDAQ: ATNX). On March 1, 2021, Athenex issued a press release reporting its fourth quarter results and disclosing receipt of a complete response letter (\u201cCRL\u201d) from the FDA regarding its new drug application for Oral Paclitaxel Plus Encequidar for the treatment of metastatic breast cancer. In the CRL, the FDA expressed the following: Concerns about safety risks associated with increase in neutropenia-related sequelae; Concerns regarding the primary endpoint assessment conducted by the Blinded Independent Central Review (BICR); and Recommendation that Athenex conduct a new clinical trial in a patient population with metastatic &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Athenex Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Athenex, Inc.&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-449919","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Athenex Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Athenex, Inc. - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Athenex Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Athenex, Inc. - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, March 03, 2021 (GLOBE NEWSWIRE) &#8212; Kaplan Fox &amp; Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Athenex, Inc. (\u201cAthenex\u201d or the \u201cCompany\u201d) (NASDAQ: ATNX). On March 1, 2021, Athenex issued a press release reporting its fourth quarter results and disclosing receipt of a complete response letter (\u201cCRL\u201d) from the FDA regarding its new drug application for Oral Paclitaxel Plus Encequidar for the treatment of metastatic breast cancer. In the CRL, the FDA expressed the following: Concerns about safety risks associated with increase in neutropenia-related sequelae; Concerns regarding the primary endpoint assessment conducted by the Blinded Independent Central Review (BICR); and Recommendation that Athenex conduct a new clinical trial in a patient population with metastatic &hellip; Continue reading &quot;Athenex Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Athenex, Inc.&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-03T20:03:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Mzk0MyM0MDQ3MjEyIzIwMjA4OTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Athenex Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Athenex, Inc.\",\"datePublished\":\"2021-03-03T20:03:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\\\/\"},\"wordCount\":305,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4Mzk0MyM0MDQ3MjEyIzIwMjA4OTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\\\/\",\"name\":\"Athenex Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Athenex, Inc. - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4Mzk0MyM0MDQ3MjEyIzIwMjA4OTE=\",\"datePublished\":\"2021-03-03T20:03:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4Mzk0MyM0MDQ3MjEyIzIwMjA4OTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4Mzk0MyM0MDQ3MjEyIzIwMjA4OTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Athenex Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Athenex, Inc.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Athenex Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Athenex, Inc. - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/","og_locale":"en_US","og_type":"article","og_title":"Athenex Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Athenex, Inc. - Market Newsdesk","og_description":"NEW YORK, March 03, 2021 (GLOBE NEWSWIRE) &#8212; Kaplan Fox &amp; Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Athenex, Inc. (\u201cAthenex\u201d or the \u201cCompany\u201d) (NASDAQ: ATNX). On March 1, 2021, Athenex issued a press release reporting its fourth quarter results and disclosing receipt of a complete response letter (\u201cCRL\u201d) from the FDA regarding its new drug application for Oral Paclitaxel Plus Encequidar for the treatment of metastatic breast cancer. In the CRL, the FDA expressed the following: Concerns about safety risks associated with increase in neutropenia-related sequelae; Concerns regarding the primary endpoint assessment conducted by the Blinded Independent Central Review (BICR); and Recommendation that Athenex conduct a new clinical trial in a patient population with metastatic &hellip; Continue reading \"Athenex Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Athenex, Inc.\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-03T20:03:13+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Mzk0MyM0MDQ3MjEyIzIwMjA4OTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Athenex Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Athenex, Inc.","datePublished":"2021-03-03T20:03:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/"},"wordCount":305,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Mzk0MyM0MDQ3MjEyIzIwMjA4OTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/","name":"Athenex Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Athenex, Inc. - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Mzk0MyM0MDQ3MjEyIzIwMjA4OTE=","datePublished":"2021-03-03T20:03:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Mzk0MyM0MDQ3MjEyIzIwMjA4OTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Mzk0MyM0MDQ3MjEyIzIwMjA4OTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athenex-investor-alert-kaplan-fox-investigates-potential-securities-fraud-at-athenex-inc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Athenex Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Athenex, Inc."}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/449919","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=449919"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/449919\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=449919"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=449919"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=449919"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}